Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Bupivacaine

Menu
$ API Ref.Price (USD/KG) : 900Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 64HERON THERAPS INC

02 6INNOCOLL

03 28PACIRA PHARMS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 11413350

Drug Substance Claim :

Drug Product Claim :

Application Number : 211988

Patent Use Code : U-3417

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

02

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 11413350

Drug Substance Claim :

Drug Product Claim :

Application Number : 211988

Patent Use Code : U-3417

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

03

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 11413350

Drug Substance Claim :

Drug Product Claim :

Application Number : 211988

Patent Use Code : U-3417

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

04

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 11413350

Drug Substance Claim :

Drug Product Claim :

Application Number : 211988

Patent Use Code : U-3417

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

05

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 9592227

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211988

Patent Use Code : U-3118

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-13

blank

06

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 9694079

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211988

Patent Use Code : U-3118

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

07

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 9801945

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211988

Patent Use Code : U-3118

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

08

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 9592227

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211988

Patent Use Code : U-3118

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-13

blank

09

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 9694079

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211988

Patent Use Code : U-3118

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank

10

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

BUPIVACAINE; MELOXICAM

US Patent Number : 9801945

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211988

Patent Use Code : U-3118

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-20

blank